4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

5.04 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 187.539189.061275.594249.108275.678310.343201.85952.351108.298113.48475.97153.00190.989243.743259.865276.72688.755-49.65249.652-72.86972.86972.86991.76191.761-23.85
Short Term Investments 314.353352.885250.31739.12443.98674.032121.885161.203119.417127.604160.18394.77670.686000099.3040145.738000047.7
Cash and Short Term Investments 501.892541.946525.911288.232319.664310.343201.859213.554227.715241.088236.153247.777161.675243.743259.865276.72688.75549.65249.65272.86972.86972.86991.76191.76123.85
Net Receivables 000000000000.0470.7911.2180.9651.4860.89600.97801.1611.1611.1241.1240
Inventory 0000000-0.700000000000000000
Other Current Assets 8.86510.6879.6788.3568.5797.4336.5866.9579.52610.8713.7888.4566.5347.5823.6714.4441.38501.87801.4151.4150.7831.1830
Total Current Assets 510.757552.633535.589296.588328.243310.343207.04220.511232.478246.523243.047256.28165.733248.752264.501282.65692.53649.65252.50872.86975.44575.44594.06894.06823.85
Non-Current Assets:
Property, Plant & Equipment, Net 41.62829.44930.58231.66532.68833.64734.31635.34735.51134.91832.64228.9538.7895.585.0115.0734.98105.04904.0264.0262.4722.4720
Goodwill 0000000000000000000000000
Intangible Assets 0000000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000000
Long Term Investments 48.77935.71562.94210.954001.4054.90811.12220.53248.36267.65265.494000000000000
Tax Assets 0000000000000000000000000
Other Non-Current Assets 2.8642.320.7710.6840.6828.5131.261.081.0530.9630.8750.6020.6020.6020.6020.6020.675-49.6520.677-72.8691.0291.0290.4290.429-23.85
Total Non-Current Assets 93.27167.48494.29543.30333.3742.1636.98141.33547.68656.41381.87997.20774.8856.1825.6135.6755.656-49.6525.726-72.8695.0555.0552.9012.901-23.85
Total Assets 604.028620.117629.884339.891361.613352.503244.021261.846280.164302.936324.926353.487240.618254.934270.114288.33198.192058.234080.580.596.96996.9690
Liabilities & Equity:
Current Liabilities:
Account Payables 2.9243.4314.2173.5154.7133.4932.4083.3221.483.3162.6814.7643.7131.9621.2841.7871.29201.74401.1151.1150.9540.9540
Short Term Debt 5.0916.3923.1733.1496.2526.2062.6782.6555.2665.1924.0741.2310000000000000
Tax Payables 000000000000000000000.18100.09300
Deferred Revenue 0.03501.3220.2730.130.5760.7780.8842.2072.2562.1092.5991.7283.0167.0876.5865.61905.86404.24604.90700
Other Current Liabilities 21.4159.589.01312.0147.9132.995.4148.875.0614.2013.5327.7445.9324.8925.5458.3717.36705.34703.0617.4882.17.10
Total Current Liabilities 29.46519.40316.40318.95118.16313.74911.27815.73113.56414.33112.09116.33811.3739.8713.91616.74414.278012.95508.6038.6038.0548.0540
Non-Current Liabilities:
Long Term Debt 19.74310.4610.99811.52212.03112.52713.00513.46913.91914.40214.78215.2170000000000000
Deferred Revenue Non-Current 01.3181.3220.9721.0960.8470.8841.0761.0011.4521.7612.4913.012.34211.6913.22611.731013.603010.777013.07600
Deferred Tax Liabilities Non-Current 0000.3690.3690.2120000000000000000000
Other Non-Current Liabilities 1.8720.5960.60.6170.3890.2360.2480.2330.2360.2340.2360.3342.1012.0762.0771.97413.7580104.6460103.4240103.42600
Total Non-Current Liabilities 21.61512.37412.9213.11113.51613.6114.13714.77815.15616.08816.77918.0425.1114.41813.76715.213.7580118.2490114.2010116.50200
Total Liabilities 51.0831.77729.32332.06231.679725.29125.41530.50928.7230.41928.8734.3816.48414.28827.68331.94428.0360131.2040122.8048.603124.5568.0540
Equity:
Preferred Stock 0000000000000000175.448102.98102.98102.98102.98102.98102.98102.9818.508
Common Stock 0.0050.0050.0050.0040.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.00200.00100.0010.0010.0010.0010
Retained Earnings -526.524-482.681-447.728-415.327-383.044-372.788-343.172-314.49-287.111-261.42-233.334-206.996-181.913-159.674-152.085-135.679-115.1320-79.0250-46.235-46.235-30.026-30.0260
Accumulated Other Comprehensive Income/Loss 0-0.293-0.1090.0160.5340.345-0.27-1.196-1.851-1.827-1.421-0.423-0.195000-175.448-72.97-102.98-42.304-102.980-102.980-19.59
Other Total Stockholders Equity 1,079.4671,071.3091,048.393723.136712.44697.583562.045547.02540.403535.761530.808526.523406.239400.317394.513392.0639.83806.0540209.893.93208.3982.4380
Total Shareholders Equity 552.948588.34600.561307.829329.934-372.788-343.172231.337251.444272.517296.056319.107224.134240.646242.431256.38770.15630.01-72.9760.676-42.30460.676-27.58775.393-1.082
Total Equity 552.948588.34600.561307.829329.934-372.788-343.172231.337251.444272.517296.056319.107224.134240.646242.431256.38770.15630.01-72.9760.676-42.30460.676-27.58775.393-1.082
Total Liabilities & Shareholders Equity 604.028620.117629.884339.891361.613352.503-317.757261.846280.164302.936324.926353.487240.618254.934270.114288.33198.19230.0158.23460.67680.569.27996.96983.447-1.082